Skip to main content

Enkephalin is a competitive antagonist of cholecystokinin in the gastrointestinal tract, as predicted from prior conformational analysis

Abstract

Prior calculations based on ECEPP (Empirical Conformational Energies for Peptides Program) of the low energy minima for cholecystokinin (CCK) and Met-enkephalin have demonstrated that significant structural features of these two peptides are identical. This result suggested the possibility that Met-enkephalin, as well as other enkephalin analogues of similar structure, could associate with receptors for CCK. To test this theoretical result, we examined the ability of Met-enkephalin and its analogues to bind to peripheral CCK receptors in the rat gastrointestinal tract; in particular, we measured the ability of the opiate peptide to inhibit the effects of CCK in a physiological assay system which we have previously characterized: CCK-induced contraction of the isolated rat pyloric sphincter. We find that Met-enkephalin is an antagonist of the CCK-8-induced contraction, with a IC50 of 110 nM. Furthermore, antibodies against CCK were found to cross-react with Met-enkephalin and its analogues in a manner which suggests a distinct structure-activity relationship. These experimental results strongly support the theoretical results of conformational analysis showing structural similarity between enkephalin and CCK. They further suggest that enkephalins could modulate the response of CCK systems under physiological conditions.

This is a preview of subscription content, access via your institution.

References

  • Allescher, H.-D., Daniel, E. E., Dent, J., Fox, J. E. T., and Kostolaska, F. (1988).J. Physiol. (London)401, 17–38.

    Google Scholar 

  • Antin, J., Gibbs, J., Holt, J., Young, R. C., and Smith, G. P. (1975).J. Comp. Physiol. Psych. 89, 784–790.

    Google Scholar 

  • Beinfeld, M. C., Meyer, D. R., Eskay, D. L., Jensen, R. T., and Brownstein, M. J. (1979).Brain Res. 212, 51–57.

    Google Scholar 

  • Chang, R. S. L., Lotti, V. J., Chen, T. B., and Kunkel, K. A. (1986).Mol. Pharm. 30, 212–217.

    Google Scholar 

  • Chang, R. S. L., and Lotti, V. J. (1986).Proc. Natl. Acad. Sci. USA 83, 4923–4926.

    Google Scholar 

  • Cox, K. L., Schrenck, T. M., Moran, T. H., Gardner, J. D., and Jensen, R. T. (1990).Am. J. Physiol. 259, G873-G881.

    Google Scholar 

  • Evans, B. E., Bock, M. G., Rittle, K. E., DiPardo, R. M., Whitter, W. L., Veber, D. F., Anderson, P. S., and Friedinger, R. M. (1986).Proc. Natl. Acad. Sci. USA 83, 4918–4922.

    Google Scholar 

  • Gintzler, A. R., and Hyde, D. (1984).Proc. Natl. Acad. Sci. USA 81, 2252–2254.

    Google Scholar 

  • Grider, J. R., and Makhlouf, G. M. (1990).Am. J. Physiol. 259, G184-G190.

    Google Scholar 

  • Isogai, Y., Nemethy, G., and Scheraga, H. A. (1977).Proc. Natl. Acad. Sci. USA 74, 414–418.

    Google Scholar 

  • Katsushima, S., Adachi, H., Honda, T., Sato, S., Kusui, T., Onishi, S., Aoki, E., Noguchi, M., and Konishi, J. (1990).Am. J. Physiol. 258, G395-G403.

    Google Scholar 

  • Lotti, V. J., Pendelton, R. G., Gould, R. J., Hanson, H. M., Chang, R. S. L., and Clineschmidt, B. V. (1987).J. Pharmacol. Exptl. Therap. 241, 103–109.

    Google Scholar 

  • Moran, T. H., Robinson, P. H., Goldrich, M. S., and McHugh, P. R. (1986).Brain Res. 362, 175–179.

    Google Scholar 

  • Murphy, R. B., Smith, G. P., and Gibbs, J. (1987).Peptides 8, 127–134.

    Google Scholar 

  • Nemethy, G., Pottle, M., and Scheraga, H. A. (1983).J. Phys. Chem. 87, 1883–1887.

    Google Scholar 

  • Paine, G. H., and Scheraga, H. A. (1985).Biopolymers 24, 1391–1436.

    Google Scholar 

  • Purisima, E., and Scheraga, H. A. (1987).J. Mol. Biol. 196, 697–709.

    Google Scholar 

  • Pincus, M. R., Gerewitz, F., Wako, H., and Scheraga, H. A. (1983).J. Protein Chem. 2, 131–139.

    Google Scholar 

  • Pincus, M. R., Carty, R. P., Chen, J. M., Lubowsky, J., Avitable, M., Shah, D., Scheraga, H. A., and Murphy, R. B. (1987).Proc. Natl. Acad. Sci. USA 84, 4821–4825.

    Google Scholar 

  • Pincus, M. R., Murphy, R. B., Carty, R. P., Chen, J. M., Shah, D., and Scheraga, H. A. (1988).Peptides 9 (Suppl. 1), 145–152.

    Google Scholar 

  • Pincus, M. R. (1988).Int. J. Quantum Chemistry: Quantum Biology Symposium 15, 209–220.

    Google Scholar 

  • Reynolds, J. C., Ouyang, A., and Cohen, S. (1984).Am. J. Physiol. 246, G130-G136.

    Google Scholar 

  • Schneider, L. H., Murphy, R. B., Gibbs, J., and Smith, G. P. (1988). InCholecystokinin Antagonists (Wang, R. Y., and Schonfeld, R., eds.) A. Linn, New York, pp. 263–284.

    Google Scholar 

  • Shah, D., Chen, J. M., Carty, R. P., Pincus, M. R., and Scheraga, H. A. (1989).Int. J. Peptide Protein Res. 34, 325–332.

    Google Scholar 

  • Von Schrenck, R., Moran, T. H., Heinz-Erian, P., Gardner, J. D., and Jensen, R. T. (1988).Am. J. Physiol. 255, G512-G521.

    Google Scholar 

  • Vinayek, R., Jensen, R. Y., and Gardner, J. D. (1986).Gastroenterology 90, 1681.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Murphy, R.B., Pincus, M.R., Beinfeld, M. et al. Enkephalin is a competitive antagonist of cholecystokinin in the gastrointestinal tract, as predicted from prior conformational analysis. J Protein Chem 11, 723–729 (1992). https://doi.org/10.1007/BF01024973

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01024973

Key words

  • Enkephalin
  • lowest energy conformation
  • cholecystokinin
  • cholecystokinin receptor
  • opiate receptor